192 related articles for article (PubMed ID: 6661177)
21. Absence of branched chain acyl-transferase as a cause of maple syrup urine disease.
Danner DJ; Armstrong N; Heffelfinger SC; Sewell ET; Priest JH; Elsas LJ
J Clin Invest; 1985 Mar; 75(3):858-60. PubMed ID: 3980729
[TBL] [Abstract][Full Text] [Related]
22. E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype.
Chuang JL; Cox RP; Chuang DT
J Clin Invest; 1997 Aug; 100(3):736-44. PubMed ID: 9239422
[TBL] [Abstract][Full Text] [Related]
23. Gene preference in maple syrup urine disease.
Nellis MM; Danner DJ
Am J Hum Genet; 2001 Jan; 68(1):232-7. PubMed ID: 11112664
[TBL] [Abstract][Full Text] [Related]
24. Study on established lymphoid cells in maple syrup urine disease. Correlation with clinical heterogeneity.
Jinno Y; Akaboshi I; Katsuki T; Matsuda I
Hum Genet; 1984; 65(4):358-61. PubMed ID: 6693123
[TBL] [Abstract][Full Text] [Related]
25. Thiamin-responsive maple-syrup-urine disease: decreased affinity of the mutant branched-chain alpha-keto acid dehydrogenase for alpha-ketoisovalerate and thiamin pyrophosphate.
Chuang DT; Ku LS; Cox RP
Proc Natl Acad Sci U S A; 1982 May; 79(10):3300-4. PubMed ID: 6954481
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of human branched-chain alpha-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease.
AEvarsson A; Chuang JL; Wynn RM; Turley S; Chuang DT; Hol WG
Structure; 2000 Mar; 8(3):277-91. PubMed ID: 10745006
[TBL] [Abstract][Full Text] [Related]
27. Complementation analysis in lymphoid cells from five patients with different forms of maple syrup urine disease.
Jinno Y; Akaboshi I; Matsuda I
Hum Genet; 1984; 68(1):54-6. PubMed ID: 6500555
[TBL] [Abstract][Full Text] [Related]
28. Divergent Induction of Branched-Chain Aminotransferases and Phosphorylation of Branched Chain Keto-Acid Dehydrogenase Is a Potential Mechanism Coupling Branched-Chain Keto-Acid-Mediated-Astrocyte Activation to Branched-Chain Amino Acid Depletion-Mediated Cognitive Deficit after Traumatic Brain Injury.
Xing G; Ren M; Verma A
J Neurotrauma; 2018 Oct; 35(20):2482-2494. PubMed ID: 29764289
[TBL] [Abstract][Full Text] [Related]
29. A molecular model of human branched-chain amino acid metabolism.
Suryawan A; Hawes JW; Harris RA; Shimomura Y; Jenkins AE; Hutson SM
Am J Clin Nutr; 1998 Jul; 68(1):72-81. PubMed ID: 9665099
[TBL] [Abstract][Full Text] [Related]
30. Human mutations affecting branched chain alpha-ketoacid dehydrogenase.
Danner DJ; Doering CB
Front Biosci; 1998 Jun; 3():d517-24. PubMed ID: 9609836
[TBL] [Abstract][Full Text] [Related]
31. Sequence of the E1 alpha subunit of branched-chain alpha-ketoacid dehydrogenase in two patients with thiamine-responsive maple syrup urine disease.
Zhang B; Wappner RS; Brandt IK; Harris RA; Crabb DW
Am J Hum Genet; 1990 Apr; 46(4):843-6. PubMed ID: 2316528
[TBL] [Abstract][Full Text] [Related]
32. A nonsense mutation (R242X) in the branched-chain alpha-keto acid dehydrogenase E1alpha subunit gene (BCKDHA) as a cause of maple syrup urine disease. Mutations in brief no. 160. Online.
Chinsky J; Appel M; Almashanu S; Costeas P; Ambulos N; Carmi R
Hum Mutat; 1998; 12(2):136. PubMed ID: 10694918
[TBL] [Abstract][Full Text] [Related]
33. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism.
She P; Van Horn C; Reid T; Hutson SM; Cooney RN; Lynch CJ
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1552-63. PubMed ID: 17925455
[TBL] [Abstract][Full Text] [Related]
34. [Maple syrup urine disease].
Indo Y
Nihon Rinsho; 2002 Apr; 60 Suppl 4():783-7. PubMed ID: 12013999
[No Abstract] [Full Text] [Related]
35. [Maple syrup urine disease].
Indo Y; Matsuda I
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):201-4. PubMed ID: 9590028
[No Abstract] [Full Text] [Related]
36. A distinct variant of intermediate maple syrup urine disease.
Gonzalez-Rios MC; Chuang DT; Cox RP; Schmidt K; Knopf K; Packman S
Clin Genet; 1985 Feb; 27(2):153-9. PubMed ID: 3978850
[TBL] [Abstract][Full Text] [Related]
37. Altered phosphorylation state of branched-chain 2-oxo acid dehydrogenase in a branched-chain acyltransferase deficient human fibroblast cell line.
Eisenstein RS; Hoganson G; Miller RH; Harper AE
J Inherit Metab Dis; 1991; 14(1):37-44. PubMed ID: 1861457
[TBL] [Abstract][Full Text] [Related]
38. Detection of heterozygotes in maple-syrup-urine disease: measurements of branched-chain alpha-ketoacid dehydrogenase and its components in cell cultures.
Chuang DT; Ku LS; Kerr DS; Cox RP
Am J Hum Genet; 1982 May; 34(3):416-24. PubMed ID: 7081220
[TBL] [Abstract][Full Text] [Related]
39. Molecular and structural analyses of maple syrup urine disease and identification of a founder mutation in a Portuguese Gypsy community.
Quental S; Macedo-Ribeiro S; Matos R; Vilarinho L; Martins E; Teles EL; Rodrigues E; Diogo L; Garcia P; Eusébio F; Gaspar A; Sequeira S; Furtado F; Lança I; Amorim A; Prata MJ
Mol Genet Metab; 2008 Jun; 94(2):148-56. PubMed ID: 18378174
[TBL] [Abstract][Full Text] [Related]
40. Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complex.
Chuang DT; Fisher CW; Lau KS; Griffin TA; Wynn RM; Cox RP
Mol Biol Med; 1991 Feb; 8(1):49-63. PubMed ID: 1943690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
